Real-time enrollment status for this homozygous familial hypercholesterolemia clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 11:23 PM UTC
| NCT Number | NCT01109368 |
| Recruiting Status | Recruiting |
| Condition | Homozygous Familial Hypercholesterolemia |
| Phase | Clinical Trial |
| Target Enrollment | 60 participants |
| Active Locations | 1 sites in the US |
| Sponsor | The Rogosin Institute |
| Last Updated on CT.gov | April 6, 2026 (Apr 6, 2026) |
As of July 17, 2026: Clinical trial NCT01109368 is currently recruiting participants. This clinical trial study for homozygous familial hypercholesterolemia is actively seeking new participants at 1 location across the United States. The study is sponsored by The Rogosin Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT01109368 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT01109368 was last updated Apr 6, 2026 (April 6, 2026). HelloStudys verifies this status automatically.